Okay, but I'm asking, if you studied it a lot, are you prepared to say somewhere that pharmaceutical companies “shall”—just like you say with proposed section 20.7—report adverse reactions?
Judy Wasylycia-Leis NDP Winnipeg North, MB
Okay, but I'm asking, if you studied it a lot, are you prepared to say somewhere that pharmaceutical companies “shall”—just like you say with proposed section 20.7—report adverse reactions?
See context to find out what was said next.